Navigation Links
Further Upgrade to 2007 Financial Guidance Based on Strong Revenue Growth; VYVANSE Demand on Track
Date:11/1/2007

taly, Spain and Ireland. Total sales for these products in 2006 were $53.8 million. Shire will also transfer to Almirall 63 employees directly affected by the sale. The sale is subject to customary consents.

As with the sale of EQUETRO, these products are being divested as they are no longer core to Shire's strategy of building market leading positions in specialty markets through the development and commercialization of global products with strong intellectual property protection.

FOSRENOL(R) (lanthanum carbonate) - Chronic Kidney Disease ("CKD")

On October 16, 2007 the Food and Drug Administration ("FDA") Cardiovascular and Renal Drugs Advisory Committee recommended the use of phosphate binders, including Shire's FOSRENOL, to treat hyperphosphatemia (elevated levels of phosphorus in the blood) in CKD stage 4 patients. The FDA Advisory Committee's recommendation is not binding on the FDA, and no time has been set by which the FDA will decide whether to follow this recommendation.

ELAPRASE(R) (idursulfase) - Hunter Syndrome

On October 17, 2007 Shire's ELAPRASE was launched in Japan following receipt of marketing and reimbursement approval. As a result of a 2003 agreement, Genzyme Corporation ("Genzyme") will manage sales and distribution of ELAPRASE in Japan. Shire's gross profit on the arrangement will equate to an effective royalty of approximately 25%-30%, but revenues will be recorded in product sales.

Milestones totaling $7 million are due to Shire from Genzyme following marketing and reimbursement approval. These milestones will be recognized into other revenue over the expected duration of the agreement.

Pipeline Highlights

JUVISTA(R) (Human TGF beta 3)

On September 12, 2007 Renovo Group plc ("Renovo") announced positive Phase 2 clinical trial results for its lead drug, JUVISTA. This is the fifth statistically significant Phase 2 efficacy trial announced by Renovo and forms part of an ongoing range of Phas
'/>"/>

SOURCE Shire plc
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. Further support for use of statins in Alzheimer’s disease
2. Clinical Impact of Activity and Abdominal Pressure on Pelvic Floor Dysfunction Need to Be Further Analyzed
3. Doctor Accused Of Misdiagnosing 208 Patients: Further Investigation Ordered
4. NHS announces further Cost cutting Measures
5. NHS Recommends Further Cost Cutting Measures
6. Medha Patkars Condition Deteriorates Further
7. Oxford Radcliffe Hospitals Warns Of Further Job Losses
8. Asia Arming up to further the AIDS fight
9. Further Studies Needed To Completely Understand About Ventricular Fibrillation
10. Further improvements envisaged at Carstairs
11. UCLA Find Yields Further Insight into Causes of Parkinson’s Diseas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... According to a May 13, 2013 New Zealand ... Botox injections have become the most popular cosmetic ... to goo.gl/8iYbD). Although it is mostly associated with women, ... makes facial wrinkles less visible by paralyzing facial muscles. The ... months. This means that people who are conscious about their ...
(Date:5/21/2013)... May 21, 2013 Diversity Focus, a ... environments for all residents in the Creative Corridor region, ... Survey at a news conference on Thursday, May 23rd ... study, conducted in 2008. , The survey ... lead and support efforts that attract, nurture and retain ...
(Date:5/21/2013)... 2013) A paper recently published in the ... physicians and scientists at the University of Colorado School ... for pulmonary fibrosis can be used to identify individuals ... looked at a fairly common variant of the gene ... the mucous produced by the bronchial tubes. While this ...
(Date:5/21/2013)... scientific and technological research So Paulo Research Foundation, FAPESP, ... investment estimated in US$ 680 million to support 17 ... of up to eleven years, subject to continuation reviews ... for the 17 RIDCs will come from FAPESP and ... and infrastructure). Host institutions will participate in a portion ...
(Date:5/21/2013)... Today, Zane Benefits, Inc. published a ... accounts. Zane Benefits, which provides comprehensive and flexible alternatives ... in defined contribution and http://HRA ... to Zane Benefits’ website, the Affordable Care Act (known ... in 2010 and impacts many areas of health care ...
Breaking Medicine News(10 mins):Health News:Botox – Is the World’s Most Popular Cosmetic Procedure Safe? 2Health News:Diversity Focus Announces Results from 2013 Creative Corridor Survey at News Conference on Thursday, May 23rd at 10:30 a.m. 2Health News:Researchers find genetic risk factor for pulmonary fibrosis 2Health News:Research at the cutting edge of knowledge 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 2Health News:Zane Benefits Publishes New Information on HRA, HSA and FSA Accounts 3
... FREMONT, Calif., May 18 SCM Microsystems, Inc. (Nasdaq: ... solutions that open the Digital World, today announced that its ... upgradeable mobile devices to receive the required certification for use ... introduction of the electronic health card in Germany. "With the ...
... protective ends of DNA, aging might be slowed, study ... may help women live longer by preventing parts of ... , Telomeres, or the end portion of chromosomes, protect ... divide, researchers speculated that preventing this shortening could protect ...
... Ohio New research suggests that exempting bars from ... of preserving bar employment, and that even the most ... a reduction in hospitality jobs. , Researchers hope the ... into future debates within municipalities and states considering the ...
... HILLS, Calif., May 18 After teasing viewers with ... will undergo plastic surgery this season, the latest episode ... the Kardashians has revealed the secrets behind former ... After undergoing ill-advised plastic surgery 25 years ago, celebrity ...
... by an average 1% over two years --- ... initiatives including smoker surcharges.TROY, Mich., May 18 ... firm, today released the results of its 2009 ... compares health benefits and trends for the current ...
... 2009) Curcumin, the major polyphenol found in turmeric, appears to ... fat tissue in mice and cell models. Researchers at the ... Tufts University (USDA HNRCA) studied mice fed high fat diets ... "Weight gain is the result of the growth and expansion ...
Cached Medicine News:Health News:SCM Microsystems' Upgradable Mobile Terminal eHealth500 Receives Certification for German eHealth Program 2Health News:SCM Microsystems' Upgradable Mobile Terminal eHealth500 Receives Certification for German eHealth Program 3Health News:SCM Microsystems' Upgradable Mobile Terminal eHealth500 Receives Certification for German eHealth Program 4Health News:Multivitamins Might Prolong Life 2Health News:Study: Smoking bans do not cause job losses in bars and restaurants 2Health News:Study: Smoking bans do not cause job losses in bars and restaurants 3Health News:Study: Smoking bans do not cause job losses in bars and restaurants 4Health News:Garth Fisher, M.D., F.A.C.S., World Renowned Plastic Surgeon and Co-Founder Of CellCeuticals(R) Biomedical Skin Treatments Revealed On E!'s Keeping Up With The Kardashians as the Surgeon Behind Bruce Jenner's New Face 2Health News:Garth Fisher, M.D., F.A.C.S., World Renowned Plastic Surgeon and Co-Founder Of CellCeuticals(R) Biomedical Skin Treatments Revealed On E!'s Keeping Up With The Kardashians as the Surgeon Behind Bruce Jenner's New Face 3Health News:McGraw Wentworth Mid-Market Group Benefits Survey Shows Health Care Costs Increasing at 6-Year Low of 5% 2Health News:McGraw Wentworth Mid-Market Group Benefits Survey Shows Health Care Costs Increasing at 6-Year Low of 5% 3Health News:Turmeric extract suppresses fat tissue growth in rodent models 2
(Date:5/21/2013)... PARK, N.J. , May 21, 2013 /PRNewswire/ ... the launch of the new Armada corporate website ... to clearly communicate Armada,s unique and first-to-market services ... service company focused on the specialty pharmacy industry. ... continued expansion of the Armada business model in ...
(Date:5/21/2013)... May 21, 2013  Cephasonics, a technology-innovation ... announced the introduction of the cQuest Ultrasound ... communications with all cQuest Ultrasound™ hardware platforms. ... including this new capability, at Hospitalar 2013 ... from May 21-24.  Cephasonics is ...
(Date:5/21/2013)... , May 21, 2013 Hurel Corporation ("Hurel"), ... microfluidic cell-based assay platforms, today announced the appointment of ... to the Company,s Board of Directors. Dr. MacDonald is ... the Schering-Plough Research Institute ("SPRI"), which was the pharmaceutical ... by Merck & Co. in 2009. Over ...
Breaking Medicine Technology:Armada Announces New Corporate Website to Showcase Expanded Services to Specialty Pharmacy Marketplace 2Cephasonics Unveils Next-Generation Wireless-Imaging Technology for cQuest Ultrasound Hardware Platforms 2Hurel Corporation Appoints Leading Pharmaceutical Executive and Toxicologist Dr. James S. MacDonald to Board of Directors 2
... N.Y. , May 27 Surgical robotic training ... of Simulated Surgical Systems, LLC (SSS) and five world renowned ... Weill Cornell Medical Center , Vattikuti Urology Institute at ... Dentistry at Robert Wood Johnson Medical School and ...
... Ankota, Inc., a Healthcare SaaS company, has launched ... enables healthcare professionals and homecare agencies to provide real-time ... and well-being.  Taking as little as 3 minutes a ... directly to families - monitoring data such as activity ...
Cached Medicine Technology:Simulated Surgical Systems, LLC Partners to Bring Simulation Advances to Surgical Training 2Simulated Surgical Systems, LLC Partners to Bring Simulation Advances to Surgical Training 3Ankota Launches Real-Time Family Communication Tool Tracking Health of Loved One 2Ankota Launches Real-Time Family Communication Tool Tracking Health of Loved One 3
The K-ASSAY Fibrinogen Control is an assayed quality control material intended for use in monitoring the accuracy and precision of the quantitative determination of fibrinogen....
The K-ASSAY Anti-Streptolysin O Control Set is intended to be used as a consistent test sample of known concentration for monitoring the performance of K-ASSAY immunoturbidimetric assay for quantifyi...
Eppendorf expands its line of benchtop microcentrifuges with the 5418. This easy-to-use microcentrifuge features a certified aerosol-tight rotor and a unique, contoured rotor bowl design to reduce no...
... The Directigen EZ Flu A+B test ... direct and qualitative detection of influenza A ... and throat swabs of symptomatic patients. The ... differentiated test, such that influenza A viral ...
Medicine Products: